Spectroscopic evaluation on pseudopolymorphs of sodium naproxen.
Differential scanning calorimetry (DSC)
Infrared (FTIR) spectroscopy
Near-infrared spectroscopy (NIR)
Pseudopolymorphism
Sodium naproxen (NpxNa)
Journal
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
ISSN: 1873-3557
Titre abrégé: Spectrochim Acta A Mol Biomol Spectrosc
Pays: England
ID NLM: 9602533
Informations de publication
Date de publication:
15 Nov 2021
15 Nov 2021
Historique:
received:
09
02
2021
revised:
20
05
2021
accepted:
22
05
2021
pubmed:
7
6
2021
medline:
6
7
2021
entrez:
6
6
2021
Statut:
ppublish
Résumé
This paper demonstrates the assessment of vibrational spectroscopy methods such as middle infrared, near infrared and Raman spectroscopy (FTIR, FT-NIR, Raman) for the identification of pseudopolymorphic forms of a model active pharmaceutical ingredient (API) - sodium naproxen (NpxNa). NpxNa, in the form of three different pseudopolymorphs, was investigated by methods dedicated for solid state characterization: DSC (differential scanning calorimetry), XPRD (powder X-ray diffraction), SEM (scanning electron microscopy) and Karl Fischer titration. Novelty in the results sourced in the usage of the method not applied so far to identify pseudopolymorphic forms of NpxNa, that is, FTIR and FT-NIR. Based on the obtained reproduceable results, various pseudopolymorphic forms were successfully evaluated. Spectroscopic data were correlated with DSC and XPRD results. It was concluded that the combination of band's variations visible on the spectra of pseudopolymorphic forms will allow to interpretate the results unequivocally in case of crucial stability tests of medicinal substance or during on-line pharmaceutical process development by FTIR, FT-NIR and Raman spectroscopy.
Identifiants
pubmed: 34091357
pii: S1386-1425(21)00595-3
doi: 10.1016/j.saa.2021.120018
pii:
doi:
Substances chimiques
Powders
0
Naproxen
57Y76R9ATQ
Sodium
9NEZ333N27
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
120018Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.